BETRF (BetterLife Pharma) Other Financing: $0.11 Mil (TTM As of Apr. 2026)


BETRF BetterLife Pharma Inc BETRF
29 GF Score
Price $0.11
! 3 Warning Signs
View Full Analysis

What is BetterLife Pharma Other Financing?

BetterLife Pharma BETRF +13.20% 29 Other Financing is $0.11 Mil as of Apr. 2026. GuruFocus rates BETRF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

BetterLife Pharma's Other Financing for the three months ended in Apr. 2026 was $-0.00 Mil.

BetterLife Pharma's Other Financing for the trailing twelve months (TTM) ended in Apr. 2026 was $0.11 Mil.

BetterLife Pharma Other Financing Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma Other Financing Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 0.37 0.00 0.04 0.16

BetterLife Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Jan26 Apr26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.11 0.00 -0.00
BETRF
29GF Score
BetterLife Pharma Inc BETRF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.11 Mil mean?
BetterLife Pharma (BETRF) has a Other Financing of $0.11 Mil as of Apr. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for BetterLife Pharma and its competitors.
Is BetterLife Pharma's Other Financing too high?
BetterLife Pharma's current Other Financing is $0.11 Mil. Overall, BetterLife Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Other Financing compare to VRTX and REGN?
BetterLife Pharma's Other Financing of $0.11 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for BetterLife Pharma and its competitors. BetterLife Pharma's current Other Financing is $0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current Other Financing of $0.11 Mil. The current Other Financing is $0.11 Mil. BetterLife Pharma's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current Other Financing is $0.11 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Other Exchanges NPAU:GermanyBETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
29GF Score

Get the complete analysis for BETRF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price